CYTARABINE INJECTION
PFIZER CANADA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of CYTARABINE INJECTION in Canada?
A shortage of CYTARABINE INJECTION 100MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 7, 2026), but it has not started yet.
Why is CYTARABINE INJECTION not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will CYTARABINE INJECTION be available again?
The manufacturer's estimated resolution date is March 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PMS-CYTARABINE
PHARMASCIENCE INC
CYTARABINE INJECTION, MYLAN STD.
MYLAN PHARMACEUTICALS ULC
AJ-CYTARABINE
AGILA JAMP CANADA INC
CYTARABINE INJECTION BP
SANDOZ CANADA INCORPORATED
CYTARABINE INJECTION
STERIMAX INC
Other Products
CYTARABINE INJ 100MG/ML
DAVID BULL LABORATORIES (PTY) LTD.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2027-03-31
~6 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02126656
Strength
100MG
Dosage Form
SOLUTION
Route
SUBCUTANEOUS INTRAVENOUS INTRATHECAL
Active Ingredient
CYTARABINE
Tier
Unrated
Last Updated
2026-08-07
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
CYTARABINE INJECTION has 3 shortage/discontinuation reports on file — this is one of them.
Other Products from PFIZER CANADA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 02511053
20MG · DIN 02511061
40MG · DIN 02511045
DIN 02544040
5MG · DIN 01947664
10MG · DIN 01947672
20MG · DIN 01947680
40MG · DIN 01947699
DIN 02237367
DIN 02237368
DIN 02237369
50MG · DIN 02401347